(1) | (10) | " (1) | * (1) | 1 (4) | 2 (78) | 4 (1) | 6 (1) | A (201) | B (82) | C (849) | D (139) | E (93) | F (47) | G (50) | H (79) | I (89) | J (26) | K (37) | L (44) | M (108) | N (69) | O (46) | P (262) | Q (26) | R (58) | S (259) | T (149) | U (46) | V (40) | W (66) | X (6) | Y (8) | Z (6) | { (2) |   (3) | イ (1) | 用 (1) | 資 (1)
Title Author Last update
TFS awhite@cdisc.org Monday, January 9, 2023 - 15:41
Terminology admincal Monday, December 19, 2022 - 17:19
Therapeutic Areas admincal Friday, December 2, 2022 - 12:14
TMF Reference Model General Meeting bklinke@cdisc.org Friday, October 21, 2022 - 12:04
TFL Designer Virtual Workshop - Part II bklinke@cdisc.org Tuesday, October 11, 2022 - 12:01
TFL Designer Virtual Workshop bklinke@cdisc.org Tuesday, September 20, 2022 - 11:10
Timed 25-Foot Walk joebenclark Monday, August 29, 2022 - 14:35
Translations - Japanese awhite@cdisc.org Thursday, July 21, 2022 - 19:28
Terms and Conditions admincal Wednesday, July 13, 2022 - 11:39
The TMF Reference Model Group and CDISC Affiliation: What’s Next? bklinke@cdisc.org Thursday, July 7, 2022 - 16:28
Trauma Symptom Checklist for Children skopko@cdisc.org Monday, June 13, 2022 - 09:27
Tatiana Sotingco awhite@cdisc.org Wednesday, June 8, 2022 - 18:00
Trial Master File Reference Model Group Officially Affiliates with CDISC awhite@cdisc.org Wednesday, April 27, 2022 - 08:51
Taisho Pharmaceutical Co., Ltd. admincal Wednesday, March 23, 2022 - 16:03
Tanner Scale Girl skopko@cdisc.org Wednesday, March 9, 2022 - 15:09
Tanner Scale Boy skopko@cdisc.org Wednesday, March 9, 2022 - 15:08
Trialwise Anonymous (not verified) Friday, March 4, 2022 - 11:58
Thread kvo Friday, March 4, 2022 - 11:52
Therapeutic Area Data Standards for Autosomal Dominant Polycystic Kidney Disease: A Report From the Polycystic Kidney Disease Outcomes Consortium (PKDOC) awhite@cdisc.org Tuesday, February 22, 2022 - 14:01
Tumor/Lesion Identification & Results admincal Friday, February 11, 2022 - 10:00
Taku Shimizu syousef@cdisc.org Friday, January 7, 2022 - 17:17
Type 1 Diabetes - Exercise and Prevention Scoping Summary syousef@cdisc.org Tuesday, January 4, 2022 - 15:15
Type 1 Diabetes Therapeutic Area User Guide Public Review bklinke@cdisc.org Tuesday, January 4, 2022 - 14:52
Therapeutic Area (TA) Standards Overview bklinke@cdisc.org Tuesday, January 4, 2022 - 14:49
The Case for Automating Clinical Data Standards jezzell@cdisc.org Tuesday, January 4, 2022 - 13:36
Top Seven CDISC Standards Issues jezzell@cdisc.org Tuesday, January 4, 2022 - 13:25
Traumatic Brain Injury TAUG d8_migrate Tuesday, January 4, 2022 - 13:19
The Need for Human Intelligence in Assessing SDTM jezzell@cdisc.org Tuesday, January 4, 2022 - 13:09
The World of Standards: CDISC and Beyond jezzell@cdisc.org Tuesday, January 4, 2022 - 13:03
Traumatic Brain Injury–Quality of Life skopko@cdisc.org Monday, December 27, 2021 - 15:19
Test of Adaptive Behavior In Schizophrenia skopko@cdisc.org Monday, December 27, 2021 - 15:00
Type 1 Diabetes Pediatrics and Devices Publication bklinke@cdisc.org Friday, December 10, 2021 - 12:45
TransCelerate BioPharma admincal Monday, December 6, 2021 - 15:28
Traumatic Brain Injury Therapeutic Area User Guide v1.0 admincal Wednesday, November 24, 2021 - 15:08
Tradecraft Clinical Research Anonymous (not verified) Thursday, October 21, 2021 - 08:47
Transition Dyspnea Index joebenclark Wednesday, October 6, 2021 - 10:11